In this Bioanalysis Zone interview, Stephanie Traub (Cancer Research UK; London, UK) discuses her work as a biomarker specialist and challenges she faces when developing biomarker strategies. Stephanie also explains the role of non-LBA assays for biomarker validation, before sharing what new technologies this field has seen in recent years.

Find out more on Bioanalysis Zone: [ Ссылка ]

свернуть